dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada Role of Inhibitors in Clinical Practice Role of Dipeptidyl Peptidase 4
Description
Weight loss averages 60-80% of excess weight
Beyond Weight Loss: Total Body Health The choice of medication often depends on your existing health profile
In EMPA-KIDNEY, a prespecified subgroup analysis showed smaller relative risk reductions among participants with lower baseline albuminuria, likely due to a lower event rate [48]
Like any treatment, it may have side effects and is not suitable for everyone
That finding surprised many researchers and requires careful interpretation
Tirzepatide (Mounjaro/Zepbound) produces superior weight loss results15-22% body weight loss vs 10-15% with semaglutide
